SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-165821
Filing Date
2022-06-02
Accepted
2022-06-02 08:35:55
Documents
19
Period of Report
2022-05-26
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d298742d8k.htm   iXBRL 8-K 29518
2 EX-10.1 d298742dex101.htm EX-10.1 14252
3 EX-99.1 d298742dex991.htm EX-99.1 5283
7 GRAPHIC g298742img100.jpg GRAPHIC 5056
8 GRAPHIC g298742img101.jpg GRAPHIC 7842
9 GRAPHIC g298742img104.jpg GRAPHIC 1194
10 GRAPHIC g298742img202.jpg GRAPHIC 3442
11 GRAPHIC g298742img204.jpg GRAPHIC 3224
  Complete submission text file 0001193125-22-165821.txt   204317

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zsan-20220526.xsd EX-101.SCH 2871
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20220526_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20220526_pre.xml EX-101.PRE 10822
13 EXTRACTED XBRL INSTANCE DOCUMENT d298742d8k_htm.xml XML 3264
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 22989324
SIC: 2834 Pharmaceutical Preparations